MDxHealth SA Price to Free Cash Flow Ratio 2018-2024 | MDXH

MDxHealth SA price to free cash flow ratio from 2018 to 2024. Price to free cash flow ratio can be defined as

MDxHealth SA Price to Free Cash Flow Ratio 2018-2024 | MDXH

MDxHealth SA price to free cash flow ratio from 2018 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$10.5B
Hims & Hers Health (HIMS)$5.7B
Inspire Medical Systems (INSP)$5.7B
Axonics (AXNX)$3.6B
IRhythm Technologies (IRTC)$2.7B
Privia Health (PRVA)$2.7B
Enovis (ENOV)$2.6B
Omnicell (OMCL)$2.3B
Azenta (AZTA)$2.2B
10x Genomics (TXG)$1.9B
Schrodinger (SDGR)$1.6B
Clover Health Investments (CLOV)$1.6B
Phreesia (PHR)$1.2B
Standard BioTools (LAB)$763M
Fulgent Genetics (FLGT)$586M
Butterfly Network (BFLY)$571M
Talkspace (TALK)$569M
Definitive Healthcare (DH)$528M
Health Catalyst (HCAT)$495M
Pulmonx (LUNG)$278M
SOPHiA GENETICS SA (SOPH)$261M
TruBridge (TBRG)$234M
P3 Health Partners (PIII)$140M
American Well (AMWL)$136M
EUDA Health Holdings (EUDA)$98M
Future Health ESG (FHLT)$65M
HeartBeam (BEAT)$63M
111 (YI)$56M
CareCloud (CCLD)$51M
Zepp Health (ZEPP)$49M